¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"effective wave length"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • effective alveolar ventilation
    1. À¯È¿ÆóÆ÷ȯ±â 2. À¯È¿ÆóÆ÷ȯ±â·®
  • effective capacity
    À¯È¿¿ëÀû
  • effective charge
    À¯È¿ÀüÇÏ
  • effective chlorine
    À¯È¿¿°¼Ò
  • effective circulating volume
    À¯È¿¼øÈ¯¿ëÀû
  • effective current
    À¯È¿Àü·ù
  • effective demand
    À¯È¿¼ö¿ä
  • effective dose
    1. À¯È¿¿ë·® 2. À¯È¿¼±·®
  • effective dose equivalent
    À¯È¿¼±·®ÇØ´ç·®
  • effective filtration pressure
    À¯È¿¿©°ú¾Ð, À¯È¿°Å¸£±â¾Ð
  • effective mass
    À¯È¿Áú·®
  • effective membrane resistance
    À¯È¿¸·ÀúÇ×
  • effective perceived noise level
    ½ÇÈ¿°¨¼ö¼ÒÀ½¼öÁØ, ½ÇÁ¦°¨°¢¼ÒÀ½¼öÁØ
  • effective quantum number
    À¯È¿¾çÀÚ¼ö
  • effective renal blood flow
    À¯È¿ÄáÆÏÇ÷·ù·®, À¯È¿½ÅÀåÇ÷·ù·®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • restriction fragment length polymorphism
    Á¦ÇÑÀýÆí±æÀÌ´ÙÇü¼º
  • biologically effective dose
    »ý¹°ÇÐÀûÀ¯È¿¼±·®
  • collective effective dose
    Áý´ÜÀ¯È¿¼±·®
  • committed effective dose
    ¿¹Å¹À¯È¿¼±·®
  • effective capacity
    À¯È¿¿ë·®
  • effective charge
    À¯È¿ÀüÇÏ
  • effective chlorine
    À¯È¿¿°¼Ò
  • effective current
    À¯È¿Àü·ù
  • effective temperature chart
    °¨°¢¿ÂµµÇ¥
  • minimal effective analgesic concentration
    ÃÖ¼ÒÈ¿°úÁøÅë³óµµ
  • effective demand
    À¯È¿¼ö¿ä
  • effective dose
    À¯È¿¿ë·®, À¯È¿¼±·®
  • individual effective dose
    °³ÀÎÀ¯È¿¿ë·®
  • mean effective dose
    Æò±ÕÀ¯È¿¼±·®
  • median effective dose
    Áß°£À¯È¿·®, Áß°£À¯È¿¼±·®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ERPF => effective renal plasma flow
    À¯È¿½ÅÇ÷ÀåÀ¯Åë·®
  • ERPF=£¾effective renal plasma flow
    À¯È¿½ÅÇ÷·ù·®.
  • MED => minimum effective dose
    ÃÖ¼ÒÈ«¹Ý·®
  • MED=> minimum effective dose
    ÃÖ¼ÒÀ¯È¿·®.
  • MED=£¾minimum effective dose
    ÃÖ¼ÒÀ¯È¿·®.
  • Gastric slow wave
    À§¼­ÆÄ(êÖßï÷î)
  • P wave
    P ÆÄ
  • S wave
    SÆÄ.
  • T wave
    TÆÄ.
  • T-wave
    T-ÆÄ
  • U wave
    UÆÄ.
  • U wave
    UÆÄ
  • V wave
    V ÆÄ
  • alpha wave
    ¾ËÆÄÆÄ ³úÆÄ(Òà÷î)ÀÇ .
  • anacrotic wave
    »óÇà°¢À¶±â¸ÆÆÄ(¡­Øæ÷î).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • crown-rump length
    µÎÁ¤-µÐºÎ (Ôéð¢-ÔëÝ») ±æÀÌ
  • dental length
    Ä¡¿­ÀÇ ±æÀÌ.
  • echo train length
    ¿¡ÄÚ ¿­ ±æÀÌ
  • fissure length
    °Ë¿­±æÀÌ
  • focal length
    ÃÊÁ¡ (õ¥ïÇ) ±æÀÌ
  • focal length
    ÃÊÁ¡°Å¸®
  • focal length
    ÃÊÁ¡ ±æÀÌ
  • force velocity length relation
    Èû¼Óµµ(áÜÓø)±æÀÌ °ü°è(μÌõ).
  • functional profile length
    ±â´ÉÀû(¿äµµ)Ãø¸é?±æÀÌ
  • gap length
    Æ´ÀÇ ±æÀÌ.
  • height length index
    ¼öÁ÷Áö¼ö(á÷òÁò¦â¦).
  • initial length
    ¿ø·¡±æÀÌ ¡ì±Ù(ÐÉ)ÀÇ¡í.
  • length of aorta
    ´ëµ¿¸Æ(ÓÞÔÑØæ)±æÀÌ.
  • length of dental arch
    Ä¡¿­±Ã(öÍæêÏá)±æÀÌ.
  • length tension diagram
    ±æÀÌÀå·Â°î¼±(¡­íåæ³ÍØàÊ).
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • peristaltic wave
    ¿¬µ¿ÆÄ
  • propagation of ultrasonic wave
    ÃÊÀ½ÆÄÀÇ ÀüÆÄ
  • pulsed wave Doppler echocardiography
    °£ÇæÆÄÇüµµÇ÷¯½ÉÃÊÀ½ÆÄ¼ú(°Ë»ç)
  • quarter wave Matching
    4ºÐÇÒÆÄÁ¶È­Ãþ
  • radio wave
    ¶óµð¿ÀÀüÆÄ, ¶óµð¿ÀÆÄ, ¹æ¼ÛÆÄ
  • shock wave
    Ãæ°ÝÆÄ
  • shock wave lithotripsy
    Ãæ°ÝÆÄ¼â¼®¼ú
  • sine wave
    ½ÎÀÎÆÄ
  • sound wave
    À½ÆÄ
  • ultrashort wave
    ÃÊ´ÜÆÄ
  • ultrasound wave
    ÃÊÀ½ÆÄ
  • wave
    ÆÄ, ÆÄµ¿
  • wave function
    ÆÄÇü±â´É
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
F wave Flutter wave; Á¶µ¿ÆÄ
S-T [segment] in electrocardiography, the portion of the segment between the end of the S wave and the b...
SW seriously wounded; short waves; sinewave; slow wave; soap and water; social worker; spike wave; spir...
SWS slow-wave sleep; spike-wave stupor; steroid-wasting syndrome; Sturge-Weber syndrome
CR Length Crown to Rump Length
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
EDE Effective Dose Equivalent
EOA Effective Orifice Area
ERPF Effective Renal Plasma Flow
E(a) Effective arterial elastance
EC50 Effective concentrations
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • average length of life
    Æò±Õ ¼ö¸í
  • crown rump length
    µÎÁ¤ µÐºÎ ±æÀÌ
  • dental length
    Ä¡¿­ÀÇ ±æÀÌ
  • echo train length
    ¿¡ÄÚ ¿­ ±æÀÌ
  • focal length
    ÃÊÁ¡ °Å¸®
    Áý±¤ ·»Áî·ÎºÎÅÍ ÃÖ´ë ÃÊÁ¡ À§Ä¡±îÁöÀÇ °Å¸®.
  • length monitoring system
    ±æÀÌ °¨Áö°è
  • length of dental arch
    Ä¡¿­±Ã ±æÀÌ
  • length of tooth
    Ä¡¾ÆÀå
    Ä¡¾ÆÀÇ ±æÀÌ.
  • optimal length
    ÃÖÀû ±æÀÌ
  • span length
    ½ºÆÒ ±æÀÌ, ½ºÆÒÀÇ ±æÀÌ
    2°³ÀÇ ÁöÁö´ë »çÀÌ¿¡ ÀÖ´Â º¸ÀÇ ±æÀÌ.
  • spatial pulse length
    °ø°£ ÆÞ½º ±æÀÌ
  • tension-length curve
    Àå·Â ±æÀÌ °î¼±
  • tension-length diagram curve
    Àå·ÂÀåµµ °î¼±
  • working length
    ±Ù°üÀå
  • amplified audible sound wave
    ÁõÆøµÈ °¡Ã» À½ÆÄ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
active length-tension curve The relationship between active isometric tension and preload (rest length) for a contracting muscle.
(05 Mar 2000)
amplified fragment length polymorphism <technique> Invented by KeyGene, a Dutch biotech company based in Wageningen, Holland. The technique is now merchandised under licence agreement by Perkin Elmer.
Selected markers are amplified in a PCR, which makes amplified fragment length polymorphism an easy and fast tool for strain identification in agriculture, botany, microbiology and animal breeding.
Acronym: AFLP
(05 Feb 1998)
arch length The amount of space required for the permanent teeth as measured from the mesial aspect of the first molar on one side to the mesial aspect of the first molar on the opposite side, as measured through the contact points along an imaginary line of the dental arch.
(05 Mar 2000)
arch length deficiency The difference between the available circumference of the dental arch and that required to accommodate the succedaneous teeth in proper alignment.
(05 Mar 2000)
available arch length <dentistry> The amount of space available for the permanent teeth around the dental arch from the first permanent molar on the left to the first permanent molar on the right.
(05 Mar 2000)
back focal length <microscopy> As measured on the principal axis, from the second lens vertex to the back focal point of the lens. It is not the equivalent of the focal length.
(05 Aug 1998)
bellows length <microscopy> The distance from the eye point to the image plane in a photomicrographic apparatus.
(05 Aug 1998)
bond length This is the distance between the nuclei of two atoms which have formed bonds with each other.
(09 Oct 1997)
passive length-tension curve The relationship between passive tension and preload (rest length) for a muscle at rest.
(05 Mar 2000)
required arch length The sum of the mesiodistal widths of the permanent teeth from first permanent molar to first permanent molar.
(05 Mar 2000)
resting length The length at rest from which a muscle develops maximum isometric tension.
(05 Mar 2000)
restriction fragment length polymorphism <molecular biology, technique> A method that allows familial relationships to be established by comparing the characteristic polymorphic patterns that are obtained when certain regions of genomic DNA are amplified (typically by PCR) and cut with certain restriction enzymes.
The variation in the length of DNA fragments produced by a restriction endonuclease that cuts at a polymorphic locus. Such variations are generated by mutations that create or abolish recognition sites for these enzymes.
This is a key tool in DNA fingerprinting, reflecting the existence of different alleles in the individual. Restriction fragment length polymorphism mapping is also used in plant breeding to see if a key trait such as disease resistance is inherited.
In principle, an individual can be identified unambiquously by restriction fragment length polymorphism hence the use of restriction fragment length polymorphism in forensic analysis of blood, hair or semen).
Similarly, if a polymorphism can be identified close to the locus of a genetic defect, it provides a valuable marker for tracing the inheritance of the defect.
Synonym: DNA fingerprinting.
Acronym: RFLP
(12 Jan 1998)
restriction length polymorphism Fragment length polymorphism, the existence of allelic forms recognizable by the length of fragments that result when the nucleotide chain is treated by a specific restriction enzyme that cleaves wherever a particular sequence of nucleotides occurs. A mutation in this sequence changes cleaving and hence the number of fragments.
(05 Mar 2000)
greatest length Measurement from the cranial to caudal end of the embryo prior to folding.
(05 Mar 2000)
positive focal length <microscopy> Any lens which converges parallel rays to a focus at the back of the lens is a positive lens and has a positive focal length. The focal length is measured from the second principal point of the lens to the point on the lens axis where the rays from an infinitely distant point are brought to focus.
See: negative focal length.
(05 Aug 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • whole-length
    ÀüÀå(Àü½Å)ÀÇ
  • wave
    Èçµé´Ù
  • Hertzian wave
    (µ¶ÀÏÀÇ ¹°¸®ÇÐÀÚ H Hertz¿¡¼­);Ç츣Ã÷ÆÄ;ÀüÀÚÆÄ
  • Rayleigh wave
    ·¹Àϸ®ÆÄ
  • Wave
    WAVESÀÇ ´ë¿ø
  • blast wave
    ÆøÇ³
  • brain wave
    ³úÆÄ;¿µ°¨;¹¦¾È
  • carrier wave
    ¹Ý¼ÛÆÄ
  • cold wave
    ÇÑÆÄ;ÄݵåÆÄ¸¶
  • compressional (compression) wave
    ¾ÐÃàÆÄ
  • delta wave
    (ÀÇ)(³úÆÄÀÇ)µ¨Å¸ÆÄ(±íÀº ¼ö¸é »óÅ ¶§ º¸ÀÓ)
  • earthquake sea wave
    ÇØÀÏ
  • electric wave
    ÀüÆÄ
  • finger wave
    ¼Õ°¡¶ó°¡ ¿þÀ̺ê(±â¸§ ¹Ù¸¥ ¸Ó¸®¸£ ¼Õ°¡¶ôÀ¸·Î ´­·¯ ¸¸µê)
  • gravitational wave
    Áß·ÂÆÄ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á